Redwood Bioscience's Series A Round

Redwood Bioscience raised a round of funding on June 06, 2011. Investors include Takeda Ventures.

Redwood Bioscience is developing SMARTag technology, a precision-protein chemical engineering platform, to produce the next generation of antibody-drug conjugates and other semi-synthetic biotherapeut…

Articles about Redwood Bioscience's Series A Round: